$CLB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CORE LABORATORIES N V.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CORE LABORATORIES N V. Get notifications about new insider transactions in CORE LABORATORIES N V for free.
Page: < prev 1 2 3 4 5 6 7 ... 18 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 04 2016 | CLB | CORE LABORATORIES ... | Hill Christopher Scott | Chief Accounting Of ... | Buy | M | 0.00 | 53 | 0 | 8,809 | 8.8 K to 8.8 K (+0.61 %) |
Apr 01 2016 | CLB | CORE LABORATORIES ... | Sodderland Jan Willem | Director | Option Exercise | A | 0.00 | 1,335 | 0 | 1,335 | |
Apr 01 2016 | CLB | CORE LABORATORIES ... | Sodderland Jan Willem | Director | Option Exercise | M | 0.00 | 1,088 | 0 | 0 | |
Apr 01 2016 | CLB | CORE LABORATORIES ... | Sodderland Jan Willem | Director | Payment of Exercise | F | 112.41 | 566 | 63,624 | 2,974 | 3.5 K to 3 K (-15.99 %) |
Apr 01 2016 | CLB | CORE LABORATORIES ... | Sodderland Jan Willem | Director | Buy | M | 0.00 | 1,088 | 0 | 3,540 | 2.5 K to 3.5 K (+44.37 %) |
Apr 01 2016 | CLB | CORE LABORATORIES ... | Ogren D John | Director | Option Exercise | A | 0.00 | 1,335 | 0 | 1,335 | |
Apr 01 2016 | CLB | CORE LABORATORIES ... | Ogren D John | Director | Option Exercise | M | 0.00 | 1,088 | 0 | 0 | |
Apr 01 2016 | CLB | CORE LABORATORIES ... | Ogren D John | Director | Payment of Exercise | F | 112.41 | 6 | 674 | 41,506 | 41.5 K to 41.5 K (-0.01 %) |
Apr 01 2016 | CLB | CORE LABORATORIES ... | Ogren D John | Director | Buy | M | 0.00 | 1,088 | 0 | 41,512 | 40.4 K to 41.5 K (+2.69 %) |
Apr 01 2016 | CLB | CORE LABORATORIES ... | van Kempen Margaret Ann | Director | Option Exercise | A | 0.00 | 1,335 | 0 | 1,335 | |
Apr 01 2016 | CLB | CORE LABORATORIES ... | van Kempen Margaret Ann | Director | Option Exercise | M | 0.00 | 1,088 | 0 | 0 | |
Apr 01 2016 | CLB | CORE LABORATORIES ... | van Kempen Margaret Ann | Director | Payment of Exercise | F | 112.41 | 566 | 63,624 | 1,419 | 2 K to 1.4 K (-28.51 %) |
Apr 01 2016 | CLB | CORE LABORATORIES ... | van Kempen Margaret Ann | Director | Buy | M | 0.00 | 1,088 | 0 | 1,985 | 897 to 2 K (+121.29 %) |
Apr 01 2016 | CLB | CORE LABORATORIES ... | Dunlap Charles L | Director | Option Exercise | A | 0.00 | 1,335 | 0 | 1,335 | |
Apr 01 2016 | CLB | CORE LABORATORIES ... | Dunlap Charles L | Director | Option Exercise | M | 0.00 | 1,088 | 0 | 0 | |
Apr 01 2016 | CLB | CORE LABORATORIES ... | Dunlap Charles L | Director | Payment of Exercise | F | 112.41 | 6 | 674 | 1,882 | 1.9 K to 1.9 K (-0.32 %) |
Apr 01 2016 | CLB | CORE LABORATORIES ... | Dunlap Charles L | Director | Buy | M | 0.00 | 1,088 | 0 | 1,888 | 800 to 1.9 K (+136.00 %) |
Apr 01 2016 | CLB | CORE LABORATORIES ... | KEARNEY MICHAEL C | Director | Option Exercise | A | 0.00 | 1,335 | 0 | 1,335 | |
Apr 01 2016 | CLB | CORE LABORATORIES ... | KEARNEY MICHAEL C | Director | Option Exercise | M | 0.00 | 1,088 | 0 | 0 | |
Apr 01 2016 | CLB | CORE LABORATORIES ... | KEARNEY MICHAEL C | Director | Payment of Exercise | F | 112.41 | 6 | 674 | 13,046 | 13.1 K to 13 K (-0.05 %) |
Apr 01 2016 | CLB | CORE LABORATORIES ... | KEARNEY MICHAEL C | Director | Buy | M | 0.00 | 1,088 | 0 | 13,052 | 12 K to 13.1 K (+9.09 %) |
Apr 01 2016 | CLB | CORE LABORATORIES ... | van Geuns Lucia | Director | Option Exercise | A | 0.00 | 1,335 | 0 | 1,335 | |
Apr 01 2016 | CLB | CORE LABORATORIES ... | van Geuns Lucia | Director | Option Exercise | M | 0.00 | 1,088 | 0 | 0 | |
Apr 01 2016 | CLB | CORE LABORATORIES ... | van Geuns Lucia | Director | Payment of Exercise | F | 112.41 | 566 | 63,624 | 617 | 1.2 K to 617 (-47.84 %) |
Apr 01 2016 | CLB | CORE LABORATORIES ... | van Geuns Lucia | Director | Buy | M | 0.00 | 1,088 | 0 | 1,183 | 95 to 1.2 K (+1,145.26 %) |
Mar 02 2016 | CLB | CORE LABORATORIES ... | Hill Christopher Scott | Chief Accounting Of ... | Option Exercise | M | 0.00 | 100 | 0 | 1,340 | |
Mar 02 2016 | CLB | CORE LABORATORIES ... | Hill Christopher Scott | Chief Accounting Of ... | Payment of Exercise | F | 108.38 | 33 | 3,577 | 8,756 | 8.8 K to 8.8 K (-0.38 %) |
Mar 02 2016 | CLB | CORE LABORATORIES ... | Hill Christopher Scott | Chief Accounting Of ... | Buy | M | 0.00 | 100 | 0 | 8,789 | 8.7 K to 8.8 K (+1.15 %) |
Feb 16 2016 | CLB | CORE LABORATORIES ... | Hill Christopher Scott | Chief Accounting Of ... | Option Exercise | A | 0.00 | 3,000 | 0 | 3,000 | |
Feb 16 2016 | CLB | CORE LABORATORIES ... | DEMSHUR DAVID M | Chief Executive Off ... | Option Exercise | A | 0.00 | 52,995 | 0 | 52,995 | |
Feb 16 2016 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP & CFO | Option Exercise | A | 0.00 | 21,260 | 0 | 21,260 | |
Feb 16 2016 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Option Exercise | A | 0.00 | 21,260 | 0 | 21,260 | |
Feb 16 2016 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Option Exercise | A | 0.00 | 3,000 | 0 | 3,000 | |
Feb 03 2016 | CLB | CORE LABORATORIES ... | Sodderland Jan Willem | Director | Buy | P | 93.90 | 300 | 28,170 | 2,452 | 2.2 K to 2.5 K (+13.94 %) |
Jan 04 2016 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP & CFO | Option Exercise | M | 0.00 | 11,721 | 0 | 0 | |
Jan 04 2016 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP & CFO | Payment of Exercise | F | 108.74 | 3,579 | 389,180 | 68,077 | 71.7 K to 68.1 K (-4.99 %) |
Jan 04 2016 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP & CFO | Buy | M | 0.00 | 11,721 | 0 | 71,656 | 59.9 K to 71.7 K (+19.56 %) |
Jan 04 2016 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Option Exercise | M | 0.00 | 3,000 | 0 | 0 | |
Jan 04 2016 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Payment of Exercise | F | 108.74 | 821 | 89,276 | 20,302 | 21.1 K to 20.3 K (-3.89 %) |
Jan 04 2016 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Buy | M | 0.00 | 3,000 | 0 | 21,123 | 18.1 K to 21.1 K (+16.55 %) |
Jan 04 2016 | CLB | CORE LABORATORIES ... | DEMSHUR DAVID M | Chief Executive Off ... | Option Exercise | M | 0.00 | 29,218 | 0 | 0 | |
Jan 04 2016 | CLB | CORE LABORATORIES ... | DEMSHUR DAVID M | Chief Executive Off ... | Payment of Exercise | F | 108.74 | 10,919 | 1,187,332 | 252,902 | 263.8 K to 252.9 K (-4.14 %) |
Jan 04 2016 | CLB | CORE LABORATORIES ... | DEMSHUR DAVID M | Chief Executive Off ... | Buy | M | 0.00 | 29,218 | 0 | 263,821 | 234.6 K to 263.8 K (+12.45 %) |
Jan 04 2016 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Option Exercise | M | 0.00 | 11,721 | 0 | 0 | |
Jan 04 2016 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Payment of Exercise | F | 108.74 | 3,579 | 389,180 | 92,190 | 95.8 K to 92.2 K (-3.74 %) |
Jan 04 2016 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Buy | M | 0.00 | 11,721 | 0 | 95,769 | 84 K to 95.8 K (+13.95 %) |
Dec 02 2015 | CLB | CORE LABORATORIES ... | Hill Christopher Scott | Chief Accounting Of ... | Option Exercise | M | 0.00 | 125 | 0 | 1,440 | |
Dec 02 2015 | CLB | CORE LABORATORIES ... | Hill Christopher Scott | Chief Accounting Of ... | Payment of Exercise | F | 117.72 | 35 | 4,120 | 8,689 | 8.7 K to 8.7 K (-0.40 %) |
Dec 02 2015 | CLB | CORE LABORATORIES ... | Hill Christopher Scott | Chief Accounting Of ... | Buy | M | 0.00 | 125 | 0 | 8,724 | 8.6 K to 8.7 K (+1.45 %) |
Oct 02 2015 | CLB | CORE LABORATORIES ... | Hill Christopher Scott | Chief Accounting Of ... | Option Exercise | M | 0.00 | 150 | 0 | 1,565 | |
Oct 02 2015 | CLB | CORE LABORATORIES ... | Hill Christopher Scott | Chief Accounting Of ... | Payment of Exercise | F | 99.02 | 42 | 4,159 | 8,599 | 8.6 K to 8.6 K (-0.49 %) |
Oct 02 2015 | CLB | CORE LABORATORIES ... | Hill Christopher Scott | Chief Accounting Of ... | Buy | M | 0.00 | 150 | 0 | 8,641 | 8.5 K to 8.6 K (+1.77 %) |
Oct 02 2015 | CLB | CORE LABORATORIES ... | Hill Christopher Scott | Chief Accounting Of ... | Option Exercise | M | 0.00 | 125 | 0 | 1,715 | |
Oct 02 2015 | CLB | CORE LABORATORIES ... | Hill Christopher Scott | Chief Accounting Of ... | Payment of Exercise | F | 111.66 | 35 | 3,908 | 8,491 | 8.5 K to 8.5 K (-0.41 %) |
Oct 02 2015 | CLB | CORE LABORATORIES ... | Hill Christopher Scott | Chief Accounting Of ... | Buy | M | 0.00 | 125 | 0 | 8,526 | 8.4 K to 8.5 K (+1.49 %) |
Jul 27 2015 | CLB | CORE LABORATORIES ... | Sodderland Jan Willem | Director | Buy | P | 106.20 | 300 | 31,860 | 2,152 | 1.9 K to 2.2 K (+16.20 %) |
Jul 01 2015 | CLB | CORE LABORATORIES ... | Hill Christopher Scott | Chief Accounting Of ... | Option Exercise | M | 0.00 | 300 | 0 | 1,840 | |
Jul 01 2015 | CLB | CORE LABORATORIES ... | Hill Christopher Scott | Chief Accounting Of ... | Payment of Exercise | F | 114.04 | 82 | 9,351 | 8,401 | 8.5 K to 8.4 K (-0.97 %) |
Jul 01 2015 | CLB | CORE LABORATORIES ... | Hill Christopher Scott | Chief Accounting Of ... | Buy | M | 0.00 | 300 | 0 | 8,483 | 8.2 K to 8.5 K (+3.67 %) |
Jul 01 2015 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Option Exercise | M | 0.00 | 1,000 | 0 | 0 | |
Jul 01 2015 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Payment of Exercise | F | 114.04 | 274 | 31,247 | 18,123 | 18.4 K to 18.1 K (-1.49 %) |
Jul 01 2015 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Buy | M | 0.00 | 1,000 | 0 | 18,397 | 17.4 K to 18.4 K (+5.75 %) |
May 13 2015 | CLB | CORE LABORATORIES ... | KEARNEY MICHAEL C | Director | Sell | S | 128.52 | 1,000 | 128,520 | 11,964 | 13 K to 12 K (-7.71 %) |
Apr 02 2015 | CLB | CORE LABORATORIES ... | Sodderland Jan Willem | Director | Option Exercise | A | 0.00 | 1,436 | 0 | 1,436 | |
Apr 02 2015 | CLB | CORE LABORATORIES ... | Sodderland Jan Willem | Director | Option Exercise | M | 0.00 | 1,141 | 0 | 0 | |
Apr 02 2015 | CLB | CORE LABORATORIES ... | Sodderland Jan Willem | Director | Payment of Exercise | F | 104.49 | 594 | 62,067 | 1,852 | 2.4 K to 1.9 K (-24.28 %) |
Apr 02 2015 | CLB | CORE LABORATORIES ... | Sodderland Jan Willem | Director | Buy | M | 0.00 | 1,141 | 0 | 2,446 | 1.3 K to 2.4 K (+87.43 %) |
Apr 02 2015 | CLB | CORE LABORATORIES ... | KEARNEY MICHAEL C | Director | Option Exercise | A | 0.00 | 1,436 | 0 | 1,436 | |
Apr 02 2015 | CLB | CORE LABORATORIES ... | KEARNEY MICHAEL C | Director | Option Exercise | M | 0.00 | 1,141 | 0 | 0 | |
Apr 02 2015 | CLB | CORE LABORATORIES ... | KEARNEY MICHAEL C | Director | Payment of Exercise | F | 104.49 | 3 | 313 | 12,964 | 13 K to 13 K (-0.02 %) |
Apr 02 2015 | CLB | CORE LABORATORIES ... | KEARNEY MICHAEL C | Director | Buy | M | 0.00 | 1,141 | 0 | 12,967 | 11.8 K to 13 K (+9.65 %) |
Apr 02 2015 | CLB | CORE LABORATORIES ... | van Kempen Margaret Ann | Director | Option Exercise | A | 0.00 | 1,436 | 0 | 1,436 | |
Apr 02 2015 | CLB | CORE LABORATORIES ... | van Kempen Margaret Ann | Director | Option Exercise | M | 0.00 | 1,141 | 0 | 0 | |
Apr 02 2015 | CLB | CORE LABORATORIES ... | van Kempen Margaret Ann | Director | Payment of Exercise | F | 104.49 | 594 | 62,067 | 897 | 1.5 K to 897 (-39.84 %) |
Apr 02 2015 | CLB | CORE LABORATORIES ... | van Kempen Margaret Ann | Director | Buy | M | 0.00 | 1,141 | 0 | 1,491 | 350 to 1.5 K (+326.00 %) |
Apr 02 2015 | CLB | CORE LABORATORIES ... | Ogren D John | Director | Option Exercise | A | 0.00 | 1,436 | 0 | 1,436 | |
Apr 02 2015 | CLB | CORE LABORATORIES ... | Ogren D John | Director | Option Exercise | M | 0.00 | 1,141 | 0 | 0 | |
Apr 02 2015 | CLB | CORE LABORATORIES ... | Ogren D John | Director | Payment of Exercise | F | 104.49 | 5 | 522 | 40,424 | 40.4 K to 40.4 K (-0.01 %) |
Apr 02 2015 | CLB | CORE LABORATORIES ... | Ogren D John | Director | Buy | M | 0.00 | 1,141 | 0 | 40,429 | 39.3 K to 40.4 K (+2.90 %) |
Apr 02 2015 | CLB | CORE LABORATORIES ... | van Geuns Lucia | Director | Option Exercise | A | 0.00 | 1,436 | 0 | 1,436 | |
Apr 02 2015 | CLB | CORE LABORATORIES ... | Dunlap Charles L | Director | Option Exercise | A | 0.00 | 1,436 | 0 | 1,436 | |
Feb 17 2015 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Option Exercise | A | 0.00 | 3,000 | 0 | 3,000 | |
Feb 17 2015 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP & CFO | Option Exercise | A | 0.00 | 17,685 | 0 | 17,685 | |
Feb 17 2015 | CLB | CORE LABORATORIES ... | DEMSHUR DAVID M | Chief Executive Off ... | Option Exercise | A | 0.00 | 44,085 | 0 | 44,085 | |
Feb 17 2015 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Option Exercise | A | 0.00 | 17,685 | 0 | 17,685 | |
Feb 03 2015 | CLB | CORE LABORATORIES ... | van Kempen Margaret Ann | Director | Buy | P | 102.07 | 250 | 25,519 | 350 | 100 to 350 (+250.00 %) |
Feb 02 2015 | CLB | CORE LABORATORIES ... | Sodderland Jan Willem | Director | Buy | P | 94.54 | 300 | 28,362 | 1,305 | 1 K to 1.3 K (+29.85 %) |
Jan 02 2015 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP & CFO | Option Exercise | M | 0.00 | 12,587 | 0 | 0 | |
Jan 02 2015 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP & CFO | Payment of Exercise | F | 0.00 | 4,735 | 0 | 61,935 | 66.7 K to 61.9 K (-7.10 %) |
Jan 02 2015 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP & CFO | Buy | M | 0.00 | 12,587 | 0 | 66,670 | 54.1 K to 66.7 K (+23.27 %) |
Jan 02 2015 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | CAO & Treasurer | Option Exercise | M | 0.00 | 3,000 | 0 | 0 | |
Jan 02 2015 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | CAO & Treasurer | Payment of Exercise | F | 0.00 | 821 | 0 | 42,384 | 43.2 K to 42.4 K (-1.90 %) |
Jan 02 2015 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | CAO & Treasurer | Buy | M | 0.00 | 3,000 | 0 | 43,205 | 40.2 K to 43.2 K (+7.46 %) |
Jan 02 2015 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Option Exercise | M | 0.00 | 12,587 | 0 | 0 | |
Jan 02 2015 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Payment of Exercise | F | 0.00 | 4,956 | 0 | 105,448 | 110.4 K to 105.4 K (-4.49 %) |
Jan 02 2015 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Buy | M | 0.00 | 12,587 | 0 | 110,404 | 97.8 K to 110.4 K (+12.87 %) |
Jan 02 2015 | CLB | CORE LABORATORIES ... | DEMSHUR DAVID M | Chief Executive Off ... | Option Exercise | M | 0.00 | 29,835 | 0 | 0 | |
Jan 02 2015 | CLB | CORE LABORATORIES ... | DEMSHUR DAVID M | Chief Executive Off ... | Payment of Exercise | F | 0.00 | 12,516 | 0 | 234,603 | 247.1 K to 234.6 K (-5.06 %) |
Jan 02 2015 | CLB | CORE LABORATORIES ... | DEMSHUR DAVID M | Chief Executive Off ... | Buy | M | 0.00 | 29,835 | 0 | 247,119 | 217.3 K to 247.1 K (+13.73 %) |
Jan 02 2015 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Option Exercise | M | 0.00 | 3,000 | 0 | 0 | |
Jan 02 2015 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Payment of Exercise | F | 120.34 | 821 | 98,799 | 18,197 | 19 K to 18.2 K (-4.32 %) |
Jan 02 2015 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Buy | M | 0.00 | 3,000 | 0 | 19,018 | 16 K to 19 K (+18.73 %) |
Nov 17 2014 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Sell | S | 138.03 | 1,000 | 138,030 | 16,018 | 17 K to 16 K (-5.88 %) |
Nov 17 2014 | CLB | CORE LABORATORIES ... | van Geuns Lucia | Director | Buy | P | 143.98 | 95 | 13,678 | 95 | 0 to 95 |
Aug 04 2014 | CLB | CORE LABORATORIES ... | Dunlap Charles L | Director | Buy | P | 147.59 | 500 | 73,795 | 800 | 300 to 800 (+166.67 %) |
Jul 31 2014 | CLB | CORE LABORATORIES ... | Sodderland Jan Willem | Director | Buy | P | 147.89 | 200 | 29,577 | 1,005 | 805 to 1 K (+24.84 %) |
Jul 28 2014 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP & CFO | Buy | P | 148.35 | 1,000 | 148,354 | 54,083 | 53.1 K to 54.1 K (+1.88 %) |
Jul 28 2014 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP & CFO | Buy | P | 147.33 | 3,205 | 472,196 | 53,083 | 49.9 K to 53.1 K (+6.43 %) |
Jul 28 2014 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP & CFO | Buy | P | 146.91 | 2,795 | 410,607 | 49,878 | 47.1 K to 49.9 K (+5.94 %) |
Jul 01 2014 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Option Exercise | M | 0.00 | 1,000 | 0 | 1,000 | |
Jul 01 2014 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Payment of Exercise | F | 167.06 | 274 | 45,774 | 17,018 | 17.3 K to 17 K (-1.58 %) |
Jul 01 2014 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Buy | M | 0.00 | 1,000 | 0 | 17,292 | 16.3 K to 17.3 K (+6.14 %) |
Apr 02 2014 | CLB | CORE LABORATORIES ... | KEARNEY MICHAEL C | Director | Option Exercise | M | 0.00 | 1,469 | 0 | 0 | |
Apr 02 2014 | CLB | CORE LABORATORIES ... | KEARNEY MICHAEL C | Director | Option Exercise | A | 0.00 | 756 | 0 | 756 | |
Apr 02 2014 | CLB | CORE LABORATORIES ... | KEARNEY MICHAEL C | Director | Payment of Exercise | F | 198.44 | 4 | 794 | 11,826 | 11.8 K to 11.8 K (-0.03 %) |
Apr 02 2014 | CLB | CORE LABORATORIES ... | KEARNEY MICHAEL C | Director | Buy | M | 0.00 | 1,469 | 0 | 11,830 | 10.4 K to 11.8 K (+14.18 %) |
Apr 02 2014 | CLB | CORE LABORATORIES ... | Sodderland Jan Willem | Director | Option Exercise | M | 0.00 | 1,469 | 0 | 0 | |
Apr 02 2014 | CLB | CORE LABORATORIES ... | Sodderland Jan Willem | Director | Option Exercise | A | 0.00 | 756 | 0 | 756 | |
Apr 02 2014 | CLB | CORE LABORATORIES ... | Sodderland Jan Willem | Director | Payment of Exercise | F | 198.44 | 764 | 151,608 | 805 | 1.6 K to 805 (-48.69 %) |
Apr 02 2014 | CLB | CORE LABORATORIES ... | Sodderland Jan Willem | Director | Buy | M | 0.00 | 1,469 | 0 | 1,569 | 100 to 1.6 K (+1,469.00 %) |
Apr 02 2014 | CLB | CORE LABORATORIES ... | Ogren D John | Director | Option Exercise | M | 0.00 | 1,469 | 0 | 0 | |
Apr 02 2014 | CLB | CORE LABORATORIES ... | Ogren D John | Director | Option Exercise | A | 0.00 | 756 | 0 | 756 | |
Apr 02 2014 | CLB | CORE LABORATORIES ... | Ogren D John | Director | Payment of Exercise | F | 198.44 | 6 | 1,191 | 39,288 | 39.3 K to 39.3 K (-0.02 %) |
Apr 02 2014 | CLB | CORE LABORATORIES ... | Ogren D John | Director | Buy | M | 0.00 | 1,469 | 0 | 39,294 | 37.8 K to 39.3 K (+3.88 %) |
Apr 02 2014 | CLB | CORE LABORATORIES ... | van Kempen Margaret Ann | Director | Option Exercise | A | 0.00 | 756 | 0 | 756 | |
Apr 02 2014 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | CAO & Treasurer | Option Exercise | M | 0.00 | 700 | 0 | 0 | |
Apr 02 2014 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | CAO & Treasurer | Payment of Exercise | F | 198.44 | 192 | 38,100 | 40,205 | 40.4 K to 40.2 K (-0.48 %) |
Apr 02 2014 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | CAO & Treasurer | Buy | M | 0.00 | 700 | 0 | 40,397 | 39.7 K to 40.4 K (+1.76 %) |
Apr 02 2014 | CLB | CORE LABORATORIES ... | Dunlap Charles L | Director | Option Exercise | A | 0.00 | 756 | 0 | 756 | |
Apr 02 2014 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Option Exercise | M | 0.00 | 700 | 0 | 0 | |
Apr 02 2014 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Payment of Exercise | F | 198.44 | 192 | 38,100 | 16,292 | 16.5 K to 16.3 K (-1.16 %) |
Apr 02 2014 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Buy | M | 0.00 | 700 | 0 | 16,484 | 15.8 K to 16.5 K (+4.43 %) |
Apr 02 2014 | CLB | CORE LABORATORIES ... | van Geuns Lucia | Director | Option Exercise | A | 0.00 | 756 | 0 | 756 | |
Mar 10 2014 | CLB | CORE LABORATORIES ... | KEARNEY MICHAEL C | Director | Sell | S | 193.09 | 859 | 165,864 | 10,361 | 11.2 K to 10.4 K (-7.66 %) |
Mar 10 2014 | CLB | CORE LABORATORIES ... | KEARNEY MICHAEL C | Director | Sell | S | 192.93 | 1,141 | 220,133 | 11,220 | 12.4 K to 11.2 K (-9.23 %) |
Mar 06 2014 | CLB | CORE LABORATORIES ... | Dunlap Charles L | Director | Buy | P | 187.70 | 200 | 37,540 | 300 | 100 to 300 (+200.00 %) |
Mar 04 2014 | CLB | CORE LABORATORIES ... | van Kempen Margaret Ann | Director | Buy | P | 184.79 | 100 | 18,479 | 100 | 0 to 100 |
Mar 04 2014 | CLB | CORE LABORATORIES ... | Sodderland Jan Willem | Director | Buy | P | 188.64 | 100 | 18,864 | 100 | 0 to 100 |
Feb 14 2014 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Sell | S | 186.64 | 1,500 | 279,960 | 15,784 | 17.3 K to 15.8 K (-8.68 %) |
Feb 10 2014 | CLB | CORE LABORATORIES ... | DAVIS MONTY L | Chief Operating Off ... | Option Exercise | A | 0.00 | 8,001 | 0 | 8,001 | |
Feb 10 2014 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | CAO & Treasurer | Option Exercise | A | 0.00 | 2,200 | 0 | 2,200 | |
Feb 10 2014 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP & CFO | Option Exercise | A | 0.00 | 8,001 | 0 | 8,001 | |
Feb 10 2014 | CLB | CORE LABORATORIES ... | DEMSHUR DAVID M | Chief Executive Off ... | Option Exercise | A | 0.00 | 19,946 | 0 | 19,946 | |
Jan 03 2014 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | CAO & Treasurer | Option Exercise | M | 0.00 | 3,500 | 0 | 0 | |
Jan 03 2014 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | CAO & Treasurer | Payment of Exercise | F | 190.95 | 977 | 186,558 | 39,697 | 40.7 K to 39.7 K (-2.40 %) |
Jan 03 2014 | CLB | CORE LABORATORIES ... | Miller Charles Brigham | CAO & Treasurer | Buy | M | 0.00 | 3,500 | 0 | 40,674 | 37.2 K to 40.7 K (+9.42 %) |
Feb 10 2014 | CLB | CORE LABORATORIES ... | Elvig Mark F | VP, Counsel & Secre ... | Option Exercise | A | 0.00 | 2,200 | 0 | 2,200 | |
Jan 03 2014 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP & CFO | Option Exercise | M | 0.00 | 13,950 | 0 | 0 | |
Jan 03 2014 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP & CFO | Payment of Exercise | F | 190.95 | 5,720 | 1,092,234 | 47,083 | 52.8 K to 47.1 K (-10.83 %) |
Jan 03 2014 | CLB | CORE LABORATORIES ... | BERGMARK RICHARD L | EVP & CFO | Buy | M | 0.00 | 13,950 | 0 | 52,803 | 38.9 K to 52.8 K (+35.90 %) |